NCT01159808 A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01158703 Aspirin and Plavix Following Coronary Artery Bypass Grafting Status TERMINATED Phase PHASE4
NCT01156246 Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01155427 Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) Status COMPLETED Phase N/A
NCT01152372 Experimental Study to Validate the Modified Glucose Disposal Test Status COMPLETED Phase PHASE1
NCT01146327 A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects Status COMPLETED Phase PHASE1
NCT01142726 Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01142700 A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I Status WITHDRAWN Phase PHASE2
NCT01137851 Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients Status COMPLETED Phase N/A
NCT01137838 Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents Status COMPLETED Phase N/A
NCT01137474 A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Status COMPLETED Phase PHASE3
NCT01136694 Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) Status COMPLETED Phase N/A
NCT01135446 Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01129427 Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01129414 Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01129388 Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects Status COMPLETED Phase PHASE1